Cargando…

Association of Histamine-2 Blockers and Proton-Pump Inhibitors With Delirium Development in Critically Ill Adults: A Retrospective Cohort Study

OBJECTIVES: Histamine-2 receptor antagonists are commonly administered for stress ulcer prophylaxis in critically ill adults and may be associated with delirium development. We aimed to determine differential associations of histamine-2 receptor antagonist or proton-pump inhibitor administration wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiddapur, Ami, Kistler, Christine E., Busby-Whitehead, Jan, Austin, C. Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357254/ https://www.ncbi.nlm.nih.gov/pubmed/34396144 http://dx.doi.org/10.1097/CCE.0000000000000507

Ejemplares similares

The Association of Selective Serotonin Reuptake Inhibitors With Delirium in Critically Ill Adults: A Secondary Analysis of the Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors ICU Study
por: Austin, C. Adrian, et al.
Publicado: (2022)

Comparison and Analysis of Delirium Induced by Histamine H(2) Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
por: Fujii, Shiro, et al.
Publicado: (2012)

Social Determinants of Health and Delirium Occurrence and Duration in Critically Ill Adults
por: Wu, Ting-Ting, et al.
Publicado: (2021)

The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019)

Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
por: Khan, Sikandar H., et al.
Publicado: (2020)

Exploring Ketamine Analgosedation Use and Its Effect on Incident Delirium in Critically Ill Adults
por: Wu, Ting Ting, et al.
Publicado: (2021)

Extreme Dysbiosis of the Microbiome in Critical Illness
por: McDonald, Daniel, et al.
Publicado: (2016)

Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer
por: Cohen, Philip R.
Publicado: (2015)

Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients
por: Arai, Nobuhiko, et al.
Publicado: (2017)

Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study
por: Huang, Minqiang, et al.
Publicado: (2021)

Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy
por: Kawara, Fumiaki, et al.
Publicado: (2017)

Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018)

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba, Iwona, et al.
Publicado: (2016)

Vitamin B(12) Deficiency Associated With Concomitant Metformin and Proton Pump Inhibitor Use
por: Long, Amanda N., et al.
Publicado: (2012)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
por: Jiang, Xin, et al.
Publicado: (2019)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Histamine and Delirium: Current Opinion
por: Chazot, Paul L., et al.
Publicado: (2019)

Association of Early Beta-Blocker Exposure and Functional Outcomes in Critically Ill Patients With Moderate to Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study
por: Kelly-Hedrick, Margot, et al.
Publicado: (2023)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2019)

Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
por: Brett, Stephen
Publicado: (2005)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
por: Kweon, Takhyeon, et al.
Publicado: (2023)

Rectal Swabs from Critically Ill Patients Provide Discordant Representations of the Gut Microbiome Compared to Stool Samples
por: Fair, Katherine, et al.
Publicado: (2019)

Impact of restrictive versus liberal transfusion and clinical outcomes in critically ill children: A retrospective observational study
por: Yuliarto, Saptadi, et al.
Publicado: (2022)

Delirium in critically ill patients
por: Bergeron, Nicolas, et al.
Publicado: (2002)

The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients
por: Khorvash, Farzin, et al.
Publicado: (2014)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Repression by Cyclic AMP Receptor Protein at a Distance
por: Lee, David J., et al.
Publicado: (2012)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020)

Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants
por: Azizollahi, Hamid Reza, et al.
Publicado: (2016)

Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
por: Mori, Hideki, et al.
Publicado: (2019)

Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
por: Cholin, Liza, et al.
Publicado: (2021)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

Biomarkers of delirium in critically ill patients
por: Van den Boogaard, M, et al.
Publicado: (2011)

Delirium management in critically ill patients
por: Calvo-Ayala, Enrique, et al.
Publicado: (2013)

Epidemiology of Bleeding in Critically Ill Children With an Underlying Oncologic Diagnosis
por: Romano, Juliana, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cp5h4crrojv022t0b7305sbno7